Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.

A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

1983 • 6,923 citations

An algorithm for the grading of activity in chronic hepatitis C

1996 • 3,858 citations

Natural history of liver fibrosis progression in patients with chronic hepatitis C

1997 • 3,027 citations

Hepatitis C Virus Infection

2001 • 2,979 citations

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

2001 • 1,432 citations

Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey

2000 • 986 citations

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C

2001 • 750 citations

A 21-year experience with major hemorrhage after percutaneous liver biopsy

1990 • 655 citations

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1999 • 587 citations

National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C

1997 • 572 citations

Management of hepatitis C

2003 • 453 citations

Liver biopsy: Complications in 1000 inpatients and outpatients

1978 • 448 citations

Host genetic factors influence disease progression in chronic hepatitis C

2000 • 412 citations

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus

1997 • 267 citations

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

2002 • 221 citations

TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis

1999 • 191 citations

HEPATIC FIBROSIS

2001 • 180 citations

Aspartate aminotransferase : alanine aminotransferase ratio in chronic hepatitis C infection: Is it a useful predictor of cirrhosis?

2000 • 173 citations

The role of liver biopsy in hepatitis C

1997 • 171 citations

Which patients with hepatitis C develop liver complications?

2000 • 165 citations

Practice and complications of liver biopsy

1993 • 153 citations

A simple biological index for detection of alcoholic liver disease in drinkers.

1991 • 144 citations

Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis.

1999 • 144 citations

Mechanisms and therapy of hepatic fibrosis: Report of the AASLD single topic basic research conference

2000 • 140 citations

Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection

1998 • 131 citations

EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus Statement

1999 • 131 citations

The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: Divergent effect on interleukin-6-stimulated genes

1996 • 63 citations

Evaluation of fibrosis and hepatitis C

1999 • 52 citations

Rat hepatic stellate cell expression of α2-macroglobulin is a feature of cellular activation: implications for matrix remodelling in hepatic fibrosis

1998 • 38 citations

[Decrease of haptoglobin serum level in patients with chronic viral hepatitis C].

1993 • 34 citations

Apolipoprotein A1 is a Serum and Tissue Marker of Liver Fibrosis in Alcoholic Patients

1989 • 26 citations

Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix

1996 • 23 citations

Localization of ?2-macroglobulin protein and messenger RNA in rat liver fibrosis: Evidence for the synthesis of ?2-macroglobulin withinSchistosoma mansoni egg granulomas

1996 • 22 citations

Serum biochemical markers of liver fibrosis in human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-coinfected patients

2002 • 12 citations